Please complete the CAPTCHA to continue
@bms.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
John Lo is listed as Chief Commercial Officer (CCO) - Beam Therapeutics at Beam Therapeutics, based in San Diego, California, United States. AeroLeads shows a work email signal at bms.com and a matched LinkedIn profile for John Lo.
John Lo previously worked as Chief Commercial Officer (CCO) at Beam Therapeutics and Strategic Advisor at Erasca, Inc.. John Lo holds Doctor Of Philosophy (Phd), Biochemistry And Molecular Biology from Massachusetts Institute Of Technology.
This section adds company-level context without repeating John Lo's masked contact details.
AeroLeads found 1 current-domain work email signal for John Lo. Compare company email patterns before reaching out.
Scientist turned strategic and commercial leader pursuing a cure for cancer and serious diseases with a successful track record of driving innovation, including cell therapy. Significant experience in building teams to grow R&D pipelines, launch successfully, and lead business development.
Listed skills include Pharmaceutical Industry, Strategy, Oncology, Biotechnology, and 15 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Cambridge, Massachusetts, Us
Building commercial readiness and shaping product and portfolio strategy for the leading gene editing company to deliver in vivo and ex vivo therapies to potentially cure serious rare and common diseases
San Diego, California, Us
Providing strategic advice to advance Erasca's deep and diverse pipeline to treat Ras mutated cancers and support the vision to "Erase Cancer".
Advised private and public stage biotechnology companies on corporate and product and portfolio strategic issues, ensuring companies maximize value of pipeline with limited resources.
Lawrence Township, Nj, Us
Led the global strategy of the largest hematology portfolio of small molecules, biologics, and cell therapies. Grew pipeline, endorsing >10 pivotal studies and advancing multiple preclinical candidates into clinic. Drove the BD strategy and led successful completion of 3 deals
Summit, New Jersey, Us
Led the global strategy of the largest hematology portfolio of small molecules, biologics, and cell therapiesBuilding a best in class cell therapy capability and leading a cross functional effort that spans commercial, medical, and manufacturing. Accelerating a diverse oncology pipeline across multiple modalities.
Cambridge, Cambridgeshire, Gb
Launched 18 products / major indications globally across 4 core franchises (Lung Cancer, IO, DDR, and Hem). Building a world class Market Access organization to support multiple new launches and shape policy agenda
Cambridge, Cambridgeshire, Gb
Built a leading Lung Cancer Franchise in targeted (TAGRISSO) and immuno-oncology (IMFINZI) based therapies. Prepared for the launch of Immuno-oncology across multiple tumor types while overseeing the growth in the in-line and pipeline lung cancer portfolio
Cambridge, Cambridgeshire, Gb
Led the successful global launch of TAGRISSO for EGFR T790M NSCLC more than doubling relevant oncology industry benchmarks. Coordinated capability building across 46 markets including successful creation of global and local diagnostics capabilities. Led development of lung cancer TA strategy and pipeline / portfolio prioritization for global lung cancer disease areas.
Basel, Baselstadt, Ch
Headed US Franchise with 6 products, $3B in sales and over 300 associates. Led 2 product launches and the integration of 2 products and 100 employees with GSK acquisition.
Basel, Baselstadt, Ch
Led an organization of 120 field reps and reimbursement specialists accountable for sales of 4 products of $1.8 B in sales.Responsible for launch of 2 new products and integration of drugs and people from GSK Oncology acquisition.
Basel, Baselstadt, Ch
Led successful turnaround of declining Oncology brand, leading to 2 years of consecutive sales growth. Revamped marketing message, led sales force of 58 specialists and 9 clinical nurse educators, and rebuilt distribution model.
Basel, Baselstadt, Ch
Drove the strategy for Novartis Pharmaceuticals. Built cross-functional implementation of Franchise based Development organization, European Market Access strategy, and increased investment in China
Us
Leader in Pharmaceuticals and Medical Products practice, with focus on Business Development / Mergers & Acquisitions. Additionally led commercial and R&D transformations across multiple small and large biopharma clients
Quick answers generated from the profile data available on this page.
John Lo works for Beam Therapeutics.
John Lo is listed as Chief Commercial Officer (CCO) - Beam Therapeutics at Beam Therapeutics.
AeroLeads has found 1 work email signal at @bms.com for John Lo at Beam Therapeutics.
John Lo is based in San Diego, California, United States while working with Beam Therapeutics.
John Lo has worked for Beam Therapeutics, Erasca, Inc., Self-Employed, Bristol-Myers Squibb, and Celgene.
You can use AeroLeads to view verified contact signals for John Lo at Beam Therapeutics, including work email, phone, and LinkedIn data when available.
John Lo holds Doctor Of Philosophy (Phd), Biochemistry And Molecular Biology from Massachusetts Institute Of Technology.
John Lo is listed with skills including Pharmaceutical Industry, Strategy, Oncology, Biotechnology, Strategic Planning, Product Launch, Cross Functional Team Leadership, and Marketing.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts